Login
cbdMD, Inc. logo

cbdMD, Inc.

cbdmd.com

What Do They Do?

Sells hemp-derived cannabinoid supplements, functional wellness products and beverages to consumers, retailers and distributors.

How Do They Make Money?

Consumers typically pay before online orders ship; wholesale buyers generally pay after the sale, with timing set by the applicable agreement.

FY2025 revenue

Who Are Their Customers?

Consumers buy through the company’s websites and phone sales, while retailers and distributors buy through the inside sales team for resale in stores and online.

Do Revenues Turn Into Profits?

No. It lost $2M in FY2025.

Operating income, FY2025
−11% of revenue
▲ +35% (Loss) vs FY2024 (−$3.3M, −17%)
Net income, FY2025
−11% of revenue
▲ +45% (Loss) vs FY2024 (−$3.7M, −19%)
Free cash flow, FY2025
−9% of revenue
▼ −201% (Loss) vs FY2024 (−$542.8K, −3%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Jun 30, 2026
Revenue
▲ +21%
vs $4.6M in Q3 FY2025
Net income
▼ −26% (Loss)
vs −$895.3K in Q3 FY2025
  • Sep 2, 2026 Agreed to acquire Twinlab supplement assets The proposed purchase includes subsidiary stock, intellectual property, inventory and receivables, subject to court approval.
  • Jan 14, 2026 Acquired Bluebird Botanicals assets The assets include its brand, online CBD marketplace, related trademarks and inventory.

Shrinking. Revenue fell 57% in 4 years, from $44.5M in FY2021 to $19.2M in FY2025, about 19% a year.

New product categories The portfolio has expanded beyond CBD brands and products to include functional mushroom supplements and hemp-derived THC beverages, alongside its cbdMD and Paw CBD lines.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support